Literature DB >> 16564794

Long-term follow-up of intermediate uveitis in children.

Joke de Boer1, Tos T J M Berendschot, Patricia van der Does, Aniki Rothova.   

Abstract

PURPOSE: To analyze the clinical manifestations, remissions, and visual prognosis of intermediate uveitis in children, and to identify the risk factors for poor visual outcome.
DESIGN: Retrospective cohort study.
METHODS: Institutional study of 32 consecutive patients examined at a tertiary referral center with intermediate uveitis and the onset of ocular disease before the age of 16 years. Numerous variables were assessed, including age and gender distribution, laboratory data, the presence of systemic diseases, onset and course of ocular inflammation, clinical features and complications, therapeutic strategies and their outcomes, remission and final visual acuity, and characteristics associated with poor visual outcome.
RESULTS: Bilateral involvement was observed in 94% of the patients. Remission was observed in seven out of 15 patients (47%) with completed follow-up of five years. For our 32 subjects, we found a mean time to remission of 6.4 years (SE 0.7, CI 5.1 to 7.7). Visual outcome was favorable as only three patients developed unilateral acuity of less than 0.1 after five-year follow-up, and no additional blind eyes manifested. No associated systemic diseases were established. Optic disk edema was the most frequent complication observed (71%). Cystoid macular edema (CME) was observed in 44% of the patients and was the most common cause of visual loss.
CONCLUSIONS: Intermediate uveitis of childhood might exhibit a self-limiting course after several years. Visual loss was limited despite the high rate of severe ocular complications.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16564794     DOI: 10.1016/j.ajo.2005.09.035

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  15 in total

Review 1.  Intermediate uveitis.

Authors:  B Manohar Babu; S R Rathinam
Journal:  Indian J Ophthalmol       Date:  2010 Jan-Feb       Impact factor: 1.848

2.  Clinical characteristics of intermediate uveitis in Tunisian patients.

Authors:  Moncef Khairallah; Kamel Hmidi; Sonia Attia; Bechir Jelliti; Wafa Hasnaoui; Sonia Zaouali; Salah Jenzeri; Salim Ben Yahia; Riadh Messaoud
Journal:  Int Ophthalmol       Date:  2010-03-05       Impact factor: 2.031

3.  Spectral domain optical coherence tomography findings of patients with pars planitis and risk factors affecting visual acuity.

Authors:  F Nilüfer Yalçındağ; Emine Temel; Emrah Gökay Özgür
Journal:  Int Ophthalmol       Date:  2021-02-09       Impact factor: 2.031

4.  Analysis of clinical features and visual outcomes of pars planitis.

Authors:  Nilufer Berker; Emine Sen; Ufuk Elgin; Cemile Ucgul Atilgan; Erdem Dursun; Pelin Yilmazbas
Journal:  Int Ophthalmol       Date:  2017-04-07       Impact factor: 2.031

5.  Use of Immunosuppressive Medications for Treatment of Pediatric Intermediate Uveitis.

Authors:  Aimee O Hersh; Spencer Cope; John F Bohnsack; Akbar Shakoor; Albert T Vitale
Journal:  Ocul Immunol Inflamm       Date:  2016-12-14       Impact factor: 3.070

6.  Clinical characteristics of intermediate uveitis in adult Turkish patients.

Authors:  Esra Kardes; Betül Ilkay Sezgin Akcay; Kansu Bozkurt; Cihan Unlu; Gurkan Erdogan; Gulunay Akcali
Journal:  Int J Ophthalmol       Date:  2015-08-18       Impact factor: 1.779

7.  Influence of optic disc leakage on objective optic nerve head assessment in patients with uveitis.

Authors:  Carsten Heinz; Katy Kogelboom; Arnd Heiligenhaus
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-11-18       Impact factor: 3.117

8.  Pediatric uveitis.

Authors:  Ilknur Tugal-Tutkun
Journal:  J Ophthalmic Vis Res       Date:  2011-10

9.  Intermediate uveitis in Indian population.

Authors:  Swapnil Parchand; Manjari Tandan; Vishali Gupta; Amod Gupta
Journal:  J Ophthalmic Inflamm Infect       Date:  2011-02-23

10.  Intermediate Uveitis Etiology, Complications, Treatment, and Outcomes in a Colombian Uveitis Referral Center.

Authors:  William Rojas-Carabali; Juliana Reyes-Guanes; Valeria Villabona-Martinez; Maria Alejandra Fonseca-Mora; Alejandra de-la-Torre
Journal:  Clin Ophthalmol       Date:  2021-06-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.